Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Columbia River Carbonates is a leading supplier of high-grade calcium carbonate products, serving various industries including pharmaceuticals, food, and industrial manufacturing. Established as a joint venture between Omya and Bleeck, the company operates a state-of-the-art processing facility in Woodland, Washington, where it produces USP-grade calcium carbonate used as an active pharmaceutical ingredient and excipient. Their products are essential for applications such as antacids, calcium supplements, and osteoporosis treatments. CRC focuses on high-purity mineral processing and maintains rigorous quality standards to meet the needs of the healthcare and life sciences sectors. The company also serves the paper, plastic, and paint industries with specialized mineral solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Columbia River Carbonates.